Short Term Intermittent Fasting and Insulin Resistance (IFAST)
Effects of Short Term Intermittent Fasting on Insulin Resistance in Type 2 Diabetes
Sponsor: Herlev Hospital
Listed as NCT02420054, this NA trial focuses on Diabetes Mellitus and Metabolic Syndrome and remains ongoing. Sponsored by Herlev Hospital, it has been updated 9 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Mar 2023 — Jul 2024 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Mar 2021 — Mar 2023 [monthly]
Active Not Recruiting NA
Status: Unknown Status → Active Not Recruiting
-
Jan 2021 — Mar 2021 [monthly]
Unknown Status NA
▶ Show 4 earlier versions
-
Jun 2019 — Jan 2021 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Jun 2018 — Jun 2019 [monthly]
Active Not Recruiting NA
-
Feb 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Apr 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Herlev Hospital
- University of Copenhagen
For direct contact, visit the study record on ClinicalTrials.gov .